(ABBI) Abraxis received two FDA Approvals for Fludarabine Phosphate as cancer drugs. (ABT) Abbott Labs $0.67 EPS vs $0.66 est. (ALGN) Align Tech traded up on positive Cramer comments on Mad Money. (ASYS) Amtech Systems announced $17.4 million in new solar orders; selling $34 million in stock. (BMY) Bristol-Myers Squibb won FDA approval for Ixempra breast cancer drug for those who have stopped responding to other treatment. (CIT) CIT Group $1.29 EPS vs $1.24 est. (CMA) Comerica $1.17 EPS vs $1.22 est. (CSX) CSX $0.67 EPS vs $0.62 est. (DLR) Digital Realty Trust priced 3.5 million shares at $39.38 in...
Close Scheduled to Occur on November 13, 2007
APP Pharmaceuticals, the Hospital-Based Business, Reports Last
Twelve Month Revenue of $653 Million and Expects Adjusted EBITDA to be
between $258 and $263 Million for the Last Twelve Months Ending
September 30, 2007
Get daily news and insights for the advertising, automotive, energy, financial services, food, health care, media, pharmaceutical, retail, technology, and travel industries.
